Duration of therapy in advanced, metastatic non-small-cell lung cancer.

Clinical advances in hematology & oncology : H&O

Volumn 1, Issue 1, 2003, Pages 33-38

  Socinski, Mark A ^a   Baggstrom, Maria Q ^a   Hensing, Thomas A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CLINICAL TRIAL; DISEASE COURSE; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; METASTASIS; MORTALITY; PATHOLOGY; SURVIVAL; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0346984014     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)